ZA200801858B - Preventive or therapeutic agent for disease caused by decrease in lacrimal fluid - Google Patents
Preventive or therapeutic agent for disease caused by decrease in lacrimal fluidInfo
- Publication number
- ZA200801858B ZA200801858B ZA200801858A ZA200801858A ZA200801858B ZA 200801858 B ZA200801858 B ZA 200801858B ZA 200801858 A ZA200801858 A ZA 200801858A ZA 200801858 A ZA200801858 A ZA 200801858A ZA 200801858 B ZA200801858 B ZA 200801858B
- Authority
- ZA
- South Africa
- Prior art keywords
- preventive
- decrease
- therapeutic agent
- disease caused
- lacrimal fluid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005247563 | 2005-08-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200801858B true ZA200801858B (en) | 2009-07-29 |
Family
ID=37808722
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200801858A ZA200801858B (en) | 2005-08-29 | 2006-08-28 | Preventive or therapeutic agent for disease caused by decrease in lacrimal fluid |
Country Status (14)
Country | Link |
---|---|
US (1) | US20100197788A9 (xx) |
EP (1) | EP1938837A4 (xx) |
JP (1) | JPWO2007026630A1 (xx) |
KR (1) | KR20080038412A (xx) |
CN (1) | CN101252952A (xx) |
AU (1) | AU2006285963A1 (xx) |
BR (1) | BRPI0615339A2 (xx) |
CA (1) | CA2619445A1 (xx) |
IL (1) | IL189620A0 (xx) |
NO (1) | NO20081550L (xx) |
RU (1) | RU2008112176A (xx) |
TW (1) | TW200744635A (xx) |
WO (1) | WO2007026630A1 (xx) |
ZA (1) | ZA200801858B (xx) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007061114A1 (ja) * | 2005-11-28 | 2007-05-31 | Kissei Pharmaceutical Co., Ltd. | 神経因性疼痛の予防又は治療用医薬組成物 |
WO2007114315A1 (ja) * | 2006-03-30 | 2007-10-11 | Santen Pharmaceutical Co., Ltd. | 角結膜障害治療剤 |
EP2123268A1 (en) * | 2007-02-21 | 2009-11-25 | Kissei Pharmaceutical Co., Ltd. | Pharmaceutical composition for prevention or treatment of disease associated with tear reduction |
JPWO2010041568A1 (ja) | 2008-10-09 | 2012-03-08 | 旭化成ファーマ株式会社 | インダゾール誘導体 |
AU2009301798B2 (en) | 2008-10-09 | 2012-03-01 | Asahi Kasei Pharma Corporation | Indazole compound |
US20100222404A1 (en) * | 2008-11-04 | 2010-09-02 | Asahi Kasei Pharma Corporation | Indazole derivative dihydrochloride |
US8778998B2 (en) | 2009-04-10 | 2014-07-15 | Auspex Pharmaceuticals, Inc. | Biphenyl-3-carboxylic acid modulators of beta-3-adrenoreceptor |
EP2506843A4 (en) * | 2009-12-02 | 2013-04-17 | Bridge Pharma Inc | TREATMENT OF THE DRY EYE WITH COMPOUNDS TO INCREASE MOMENTUM DRY SECRETION |
WO2014108449A1 (en) | 2013-01-08 | 2014-07-17 | Atrogi Ab | A screening method, a kit, a method of treatment and a compound for use in a method of treatment |
GB201612165D0 (en) * | 2016-07-13 | 2016-08-24 | Atrogi Ab | Combinations for the treatment of type 2 diabetes |
GB201714745D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
GB201714736D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
GB201714740D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
GB201714734D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5768684A (en) * | 1994-03-04 | 1998-06-16 | Motorola, Inc. | Method and apparatus for bi-directional power control in a digital communication system |
KR980007105A (ko) * | 1996-06-28 | 1998-03-30 | 김광호 | 이동국 송신전력 제어방법 |
ID24062A (id) * | 1997-07-25 | 2000-07-06 | Kissei Pharmaceutical | Turunan-turunan asam aminoetilfenoksiasetat dan obat untuk mengurangi nyeri dan membantu penyingkiran dalam litiasis saluran air kencing |
MY126489A (en) * | 1998-07-08 | 2006-10-31 | Kissei Pharmaceutical | Phenoxyacetic acid derivatives and medicinal compositions containing the same |
US6064659A (en) * | 1998-07-10 | 2000-05-16 | Motorola, Inc. | Method and system for allocating transmit power to subscriber units in a wireless communications system |
JP3471662B2 (ja) * | 1998-08-28 | 2003-12-02 | 松下電器産業株式会社 | 送受信装置及びその送信電力制御方法 |
US6311070B1 (en) * | 1999-03-22 | 2001-10-30 | Nortel Networks Limited | Variable step size for power control bits to protect against power overshoot |
EP1045529B1 (en) * | 1999-04-12 | 2006-11-29 | Alcatel | A method for improving performances of a mobile radiocommunication system using a power control algorithm |
WO2001041806A1 (fr) | 1999-12-07 | 2001-06-14 | Rohto Pharmaceutical Co., Ltd. | Compositions ophtalmiques |
KR100324425B1 (ko) * | 1999-12-29 | 2002-02-27 | 박종섭 | Cdma 시스템에서의 기지국 및 이동국간 순방향/역방향링크 전력제어 방법 |
JP2001268637A (ja) * | 2000-03-15 | 2001-09-28 | Nec Corp | 移動機及び基地局並びにそれ等を用いた移動通信システム |
CA2313290A1 (en) * | 2000-06-30 | 2001-12-30 | Frank Van Heeswyk | Adaptive rate power control cdma system |
US6856644B1 (en) * | 2000-10-31 | 2005-02-15 | Motorola, Inc. | Method and apparatus for forward link power control bit generation in a spread-spectrum communication system |
JP3577021B2 (ja) * | 2001-09-12 | 2004-10-13 | 埼玉日本電気株式会社 | 移動局および移動局における電界状態判定方法 |
AU2004212381B2 (en) | 2003-02-14 | 2008-08-21 | Kissei Pharmaceutical Co., Ltd. | Amino alcohol derivatives, pharmaceutical compositions containing the same, and use thereof |
-
2006
- 2006-08-28 CA CA002619445A patent/CA2619445A1/en not_active Abandoned
- 2006-08-28 KR KR1020087006579A patent/KR20080038412A/ko not_active Application Discontinuation
- 2006-08-28 AU AU2006285963A patent/AU2006285963A1/en not_active Abandoned
- 2006-08-28 RU RU2008112176/15A patent/RU2008112176A/ru not_active Application Discontinuation
- 2006-08-28 JP JP2007533219A patent/JPWO2007026630A1/ja not_active Withdrawn
- 2006-08-28 EP EP06796870A patent/EP1938837A4/en not_active Withdrawn
- 2006-08-28 ZA ZA200801858A patent/ZA200801858B/xx unknown
- 2006-08-28 CN CNA2006800318183A patent/CN101252952A/zh active Pending
- 2006-08-28 BR BRPI0615339-9A patent/BRPI0615339A2/pt not_active IP Right Cessation
- 2006-08-28 WO PCT/JP2006/316836 patent/WO2007026630A1/ja active Application Filing
- 2006-08-29 TW TW095131667A patent/TW200744635A/zh unknown
-
2008
- 2008-02-19 US US12/070,495 patent/US20100197788A9/en not_active Abandoned
- 2008-02-20 IL IL189620A patent/IL189620A0/en unknown
- 2008-03-31 NO NO20081550A patent/NO20081550L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
US20080306160A1 (en) | 2008-12-11 |
WO2007026630A1 (ja) | 2007-03-08 |
JPWO2007026630A1 (ja) | 2009-03-05 |
CN101252952A (zh) | 2008-08-27 |
IL189620A0 (en) | 2008-06-05 |
KR20080038412A (ko) | 2008-05-06 |
BRPI0615339A2 (pt) | 2011-05-17 |
CA2619445A1 (en) | 2007-03-08 |
US20100197788A9 (en) | 2010-08-05 |
EP1938837A1 (en) | 2008-07-02 |
AU2006285963A1 (en) | 2007-03-08 |
RU2008112176A (ru) | 2009-10-10 |
NO20081550L (no) | 2008-05-28 |
TW200744635A (en) | 2007-12-16 |
EP1938837A4 (en) | 2010-07-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200801858B (en) | Preventive or therapeutic agent for disease caused by decrease in lacrimal fluid | |
EP1962961A4 (en) | HALF-BODY: THERAPEUTIC AGENTS ACTIVATED BY DIMÉRIZATION | |
PL3424932T3 (pl) | Boronoftalidy do zastosowania terapeutycznego | |
IL185250A0 (en) | Microimplants for ocular administration | |
GB0506147D0 (en) | Therapeutic agents | |
GB0521139D0 (en) | Therapeutic agent | |
GB0615545D0 (en) | Therapeutic agent | |
GB0519797D0 (en) | Therapeutic agents | |
GB0505437D0 (en) | Therapeutic agents | |
GB0505725D0 (en) | Therapeutic agents | |
GB0518819D0 (en) | Therapeutic agents | |
GB0519350D0 (en) | Therapeutic agents | |
EP1915998A4 (en) | PROPHYLACTIC OR THERAPEUTIC AGENT FOR CORNEAL OR CONJUNCTIVAL DISEASE | |
GB0518817D0 (en) | Therapeutic agents | |
GB0516661D0 (en) | Therapeutic agents | |
GB0514738D0 (en) | Therapeutic agents | |
EP1974732A4 (en) | THERAPEUTIC AGENT FOR NEURODEGENERATIVE DISEASE | |
EP1839653A4 (en) | THERAPEUTIC AGENT FOR THE TREATMENT OF SENSORY ANOMALY | |
EP1806137A4 (en) | THERAPEUTIC AGENT FOR THE TREATMENT OF GLOMERULAR DISEASE | |
EP1859795A4 (en) | THERAPEUTIC AGENT FOR OPHTHALMIC DISEASES | |
PL1876175T3 (pl) | Środek terapeutyczny do leczenia chorób rogówki | |
GB0523998D0 (en) | Therapeutic agents | |
PL1927353T3 (pl) | Środek leczniczy na dolegliwości rogówki | |
GB0508153D0 (en) | Therapeutic agent | |
EP1958949A4 (en) | THERAPEUTIC AGENT AGAINST HORNHAUT / BINDEHAUT DISEASE |